Status:

COMPLETED

Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia

Lead Sponsor:

yangjie

Conditions:

Bronchopulmonary Dysplasia

Thrombocytopenia

Eligibility:

All Genders

Brief Summary

To investigate the relationship between bronchopulmonary dysplasia and thrombocytopenia.

Detailed Description

A prosepective case-control study ,the case were matched with 1:1according to gestational age,birth weight and admission diagnosis and divided into two groups according to the consensus definition of ...

Eligibility Criteria

Inclusion

  • presence of clinical and radiologic signs of BPD, according to conventional criteria (Greenough, 1992);
  • presence of peripheral arterial catheter;
  • gestation \<32 weeks;
  • birth weight \<1.5 kg;
  • requiring mechanical ventilation for the treatment of respiratory distress syndrome for at least 3 days during the first weeks of life;
  • ventilator and/or oxygen dependent at time of enrolment;

Exclusion

  • congenital abnormalities;
  • infection (bacteria infection confirmed by positive blood culture or viral infection confirmed by serological test or viral culture)
  • evidence of complications of perinatal asphyxia including an apgar score \<3 at one or five minute after birth, evidence of hypoxic-ischemic encephalopathy, acute tubular necrosis, or transient myocardial ischemia;
  • identifiable hematologic disease;

Key Trial Info

Start Date :

January 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2020

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT04348799

Start Date

January 1 2019

End Date

January 1 2020

Last Update

April 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Jie Yang

Guangzhou, Guangdong, China, 511442